Finnrick - Ensuring a Safer and More Transparent Supply Chain
Qingdao Saber Technology Pharma QST

Qingdao Saber Technology Pharma QST

Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Qingdao Saber Technology Pharma QST between 3 Jun 2025 and 11 Dec 2025. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
Qingdao Saber Technology Pharma QST
Retatrutide
Tested 6 Samples
Last test 11 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Qingdao Saber Technology Pharma QST

Samples are tested in commercial labs

Tests Count

6

Scores

AVG6.3MIN4.7MAX10.0

Last

11 Dec 2025

First

3 Jun 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
11 Dec 2025View10.010mg10.4mg+4.0%99.92%R1025Ja01No Label / Silver Crimp / Clear Blue CapLab EPublic
1 Sep 2025View4.75mg5.68mg+13.6%99.45%(no batch ID)No Label / Silver Crimp / Clear Blue Cap Lab FPublic
4 Aug 2025View5.510mg9.89mg-1.1%98.52%(no batch ID)No Label / Copper Crimp / Clear CapLab EPublic
17 Jul 2025View5.610mg8.46mg-15.4%99.94%(no batch ID)White Label / Silver Crimp / Blue CapLab EPublic
9 Jun 2025View4.820mg24.9mg+24.5%99.85%(no batch ID)No Label / Silver Crimp / Yellow Cap Lab EPublic
3 Jun 2025View7.320mg20.2mg+1.0%99.62%(no batch ID)No Label / Silver Crimp / Yellow CapLab EPublic